Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

IMMUCELL CORP (ICCC)

26 + Investors. Track Smart Money conviction in ICCC. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +1
Streak
2Q ▲
Buyers last Q
58%

Smart Money Signals — ICCC

Based on 26 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added ICCC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 87% of 3.0Y peak

87% of all-time peak
26 funds currently hold this stock — 87% of the 3.0-year high of 30 funds (reached 2023 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding ICCC is almost the same as a year ago (+0 funds, +0% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 58% buying

11 buying8 selling
Last quarter: 11 funds bought or added vs 8 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~3 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 1 → 2 → 3 → 3. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

69% of holders stayed for 2+ years

■ 69% conviction (2yr+) ■ 23% medium ■ 8% new
18 out of 26 hedge funds have held ICCC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~3 new funds/quarter

4 → 1 → 2 → 3 → 3 new funds/Q
New funds entering each quarter: 1 → 2 → 3 → 3. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 77% of holders stayed 2+ years

■ 77% veterans ■ 12% 1-2yr ■ 12% new
Of 26 current holders: 20 (77%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 50% AUM from top-100 funds

50% from top-100 AUM funds
10 of 26 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in ICCC. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.6
out of 10
Low Exit Risk
Exit risk score 2.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ICCC

In 2025 Q4, 11 hedge funds were net buyers of ICCC (3 opened a new position, 8 added to an existing one), while 8 reduced or exited (6 trimmed, 2 sold completely) — a 58% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 50% of total institutional value in ICCC is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +1 funds (more new holders than closures). Total institutional holders: 26.

Hedge Fund Ownership: ICCC

How many hedge funds hold ICCC — quarterly history vs. share price
Quarterly hedge fund ownership of ICCC vs. share price

Market Analysis: ICCC

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ICCC

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy IMMUCELL CORP (ICCC) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ICCC has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 49d ago
ICCC
+56.6%
XLV
-11.8%

ICCC outperformed XLV by +68.4% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 4d ago
ICCC
+20.0%
XLV
-5.2%

Since the filing became public, ICCC outperformed XLV by +25.2% .

Interpretation: The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

5 top-rated funds 0 high-conviction
Consensus
3.4
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: ICCC
2026 Q1 Stats Unlock in 1 days 26 + Investors

Track Smart Money conviction in ICCC. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 26 25 4.0%
13F Shares 1M 1M 2.21%
Total Value $8M $8M -0.09%
New Positions 3 3 -
Increased Positions 8 4 +4
Closed Positions 2 2 -
Reduced Positions 6 7 -1
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ICCC

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

26 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ICCC. Verified SEC 13F-HR filings.

QUARTER:
Top 24 institutional holders of ICCC — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Steadtrust LLC 0.20% 54,370 $344K
2 Bleichroeder LP 0.11% 101,594 $643K
3 Militia Capital Management LLC 0.03% 18,000 $114K
4 SHUFRO ROSE & CO LLC 0.02% 35,000 $222K
5 Strategic Financial Services, Inc. 0.01% 37,000 $234K
6 Mesirow Financial Investment Management, Inc. 0.00% 42,481 $269K
7 Essex Financial Services, Inc. 0.00% 11,000 $70K
8 Cresset Asset Management, LLC 0.00% 135,267 $856K
9 RENAISSANCE TECHNOLOGIES LLC 0.00% 151,789 $961K
10 BAILARD, INC. 0.00% 10,102 $64K
11 HM PAYSON & CO 0.00% 4,000 $25K
12 HighTower Advisors, LLC 0.00% 24,354 $154K
13 Capital Advisors, Ltd. LLC 0.00% 98 —
14 MORGAN STANLEY 0.00% 221,716 $1.4M
15 VANGUARD FIDUCIARY TRUST CO 0.00% 42,669 $270K
16 VANGUARD CAPITAL MANAGEMENT LLC 0.00% 260,327 $1.6M
17 CITADEL ADVISORS LLC 0.00% 35,696 $226K
18 HARBOUR INVESTMENTS, INC. 0.00% 250 $2K
19 Advisory Services Network, LLC 0.00% 200 $1K
20 OSAIC HOLDINGS, INC. 0.00% 391 $2K
21 BlackRock, Inc. 0.00% 18,186 $115K
22 UBS Group AG 0.00% 1,113 $7K
23 JONES FINANCIAL COMPANIES LLLP 0.00% 19 —
24 WELLS FARGO & COMPANY/MN 0.00% 1 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — IMMUCELL CORP (ICCC)

What does the Smart Money Trend signal show for ICCC?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added ICCC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ICCC?

Slight buying edge — 58% buying: Last quarter: 11 funds bought or added vs 8 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ICCC holders?

Elite ownership — 50% AUM from top-100 funds: 10 of 26 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in ICCC. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ICCC?

69% of holders stayed for 2+ years: 18 out of 26 hedge funds have held ICCC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy IMMUCELL CORP (ICCC) following the 2026 Q1 hedge fund 13F filings?

As of today, ICCC has moved +20.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to -5.2% for the XLV sector ETF — an outperformance of +25.2%. Since the quarter end (March 31, 2026), ICCC has gained +56.6% vs -11.8% for XLV. The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.